Cyber Monday saleUp to 70% OFF
FFF

FIREBRICK PHARMA LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

FRE chart


Full chart

Key stats


Market capitalization
‪10.93 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.007 AUD
Net income (FY)
‪−1.18 M‬ AUD
Revenue (FY)
‪14.52 K‬ AUD
Shares float
‪137.71 M‬
Beta (1Y)
−3.90

About FIREBRICK PHARMA LIMITED


Sector
Health Technology
CEO
Peter Laurence Molloy
Headquarters
Melbourne
Website
firebrickpharma.com
Founded
2012
ISIN
AU0000197352
FIGI
BBG0140SS6M0
Firebrick Pharma Ltd. is a pharmaceutical company, which engages in the development and commercialization of nasal spray treatment for the common cold based around the potential of povidone-iodine as an antimicrobial agent. The company was founded by Peter Laurence Molloy and Stephen Goodall on April 12, 2012 and is headquartered in Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

FRE news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of FRE is 0.052 AUD — it has increased by 1.96% in the past 24 hours. Watch FIREBRICK PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange FIREBRICK PHARMA LIMITED stocks are traded under the ticker FRE.
FRE stock has fallen by −3.70% compared to the previous week, the month change is a −13.33% fall, over the last year FIREBRICK PHARMA LIMITED has showed a −16.13% decrease.
FRE reached its all-time high on Jan 31, 2022 with the price of 0.750 AUD, and its all-time low was 0.036 AUD and was reached on Oct 9, 2023. View more price dynamics on FRE chart.
See other stocks reaching their highest and lowest prices.
FRE stock is 0.00% volatile and has beta coefficient of −3.90. Track FIREBRICK PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is FIREBRICK PHARMA LIMITED there?
Yes, you can track FIREBRICK PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
FRE net income for the last half-year is ‪−277.45 K‬ AUD, while the previous report showed ‪−898.42 K‬ AUD of net income which accounts for 69.12% change. Track more FIREBRICK PHARMA LIMITED financial stats to get the full picture.
No, FRE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FIREBRICK PHARMA LIMITED EBITDA is ‪−1.18 M‬ AUD, and current EBITDA margin is ‪−27.00 K‬%. See more stats in FIREBRICK PHARMA LIMITED financial statements.
Like other stocks, FRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FIREBRICK PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FIREBRICK PHARMA LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FIREBRICK PHARMA LIMITED stock shows the sell signal. See more of FIREBRICK PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.